TRANSTHERA SCIENCES (NANJING), INC. - B - H SHARES
(HKEX: 2617)
TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.
49.720 -
-3.130
(-5.92%)
Range
49.720 - 53.450
(7.50%)
Open
53.000
Previous Close
52.850
Bid Price
49.720
Bid Volume
('000)
7
Ask Price
49.740
Ask Volume
('000)
9
Volume
('000)
1,549.5
Value
78,243,390
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
